Description
Easily and efficiently isolate highly purified human circulating tumor cells (CTCs) directly from human whole blood samples by immunomagnetic negative selection, with the EasySep™ Direct Human CTC Enrichment Kit. Widely used in published research for more than 20 years, EasySep™ combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.
In this EasySep™ negative selection procedure, unwanted cells are labeled with antibody complexes and magnetic particles called EasySep™ Direct RapidSpheres™. Unwanted cells expressing the following markers are targeted for removal: CD2, CD14, CD16, CD19, CD45, CD61, and CD66b. The magnetically labeled cells are then separated from the untouched desired CTCs by using an EasySep™ magnet and simply pouring or pipetting the desired cells into a new tube. Following magnetic cell isolation, the desired CTCs are ready for downstream applications such as flow cytometry, culture, or DNA/RNA extraction.
Learn more about how immunomagnetic EasySep™ technology works. Explore additional products optimized for your workflow, including those for cell characterization, cryopreservation, and more.